Funder
Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
Publisher
Springer Science and Business Media LLC
Reference20 articles.
1. Evans TJ, Davidson HCl, Low JM, Basarab M, Arnold A (2021) Antibiotic usage and stewardship in patients with COVID-19: too much antibiotic in uncharted waters? J Infect Prev 22:119–125. https://doi.org/10.1177/1757177420976813
2. Ministério da Saúde do Brasil (2021) NOTA INFORMATIVA Nº 9/2020-SE/GAB/SE/MS. https://portalarquivos.saude.gov.br/images/pdf/2020/May/21/Nota-informativa---Orienta----es-para-manuseio-medicamentoso-precoce-depacientes-com-diagn--stico-da-COVID-19.pdf. Accessed 1
3. ANVISA (2023) https://www.gov.br/pt-br/servicos/consultar-dados-de-vendas-de-medicamentos-controlados-antimicrobianos-e-outros. Accessed 3
4. Seppala H, Klaukka T, Vuoppio-Varkila J (1997) The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group a Streptococci in Finland. N Engl J Med 337:441–446. https://doi.org/10.1056/NEJM199708143370701. Muotiala A, Helenius H, Lager K, Huovinen P
5. Haenni M, Lupo A, Madec JY (2018) Antimicrobial resistance in Streptococcus spp. Microbiol Spectr. https://doi.org/10.1128/microbiolspec.ARBA-0008-2017